Literature DB >> 2765141

Fetus as an allograft: noncytotoxic maternal antibodies to HLA-linked paternal antigens.

A Innes1, C Cunningham, D A Power, G R Catto.   

Abstract

A cellular enzyme-linked immunospecific assay (CELISA) was used to monitor maternal humoral responses in human pregnancy. Non-cytotoxic IgG antibodies to paternal lymphocytes were detected in sera from 6 of 20 normal first trimester primigravidae and 6 of 13 multiparae. No antibody activity against lymphocytes from their partners was detected in sera from any of the 15 nulliparous women. The differences in antibody response between primigravidae and nulliparae (P = 0.024) and between multiparae and nulliparae (P = 0.005) were statistically significant. Lymphocytotoic antibodies to T- and B-lymphocytes were present in sera from three multiparae, but from none of the women in the other two groups. Family studies indicated that the non-cytotoxic pregnancy-associated maternal antibodies were directed to HLA-linked antigens (P less than 0.001). Evidence obtained using cell panels and platelet absorption suggested, however, that these antibodies were not directed to the currently recognized HLA specificities (HLA-A, -B, -C, or -DR).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2765141     DOI: 10.1111/j.1600-0897.1989.tb00565.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

1.  Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos.

Authors:  M J Wolfgang; S G Eisele; M A Browne; M L Schotzko; M A Garthwaite; M Durning; A Ramezani; R G Hawley; J A Thomson; T G Golos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Expression of allogeneic MHC class I antigens by transgenic mouse trophoblast does not interfere with the normal course of pregnancy.

Authors:  B Shomer; V Toder; I Egorov; R Ehrlich
Journal:  Transgenic Res       Date:  1998-09       Impact factor: 2.788

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.